Clinical Trial

Melatonin for Prevention of Kidney Injury

Name: Melatonin for Prevention of Kidney Injury — clinical trial record (NCT05084196)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2021-10-06; most recent amendment 2025-12-16.

Status change: Not Yet Recruiting → Recruiting 2023-08-10

Trial Details

NCT Number	NCT05084196
Lead Sponsor	Rutgers, The State University of New Jersey
Conditions	Acute Kidney Injury, Adverse Drug Event
Enrollment	300 participants
Start Date	2023-06-05
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-17